¼¼°èÀÇ ¹ÙÀÌ¿À Ã˸нÃÀå : ½ÃÀå ±Ô¸ð ¹× Á¡À¯À² ºÐ¼®(¿ø·áº°, Á¾·ùº°, ¿ëµµº°) - »ê¾÷ ¼ö¿ä ¿¹Ãø(-2030³â)
Biocatalyst Market Size and Share Analysis by Source, Type, Application - Global Industry Demand Forecast to 2030
»óǰÄÚµå : 1460734
¸®¼­Ä¡»ç : Prescient & Strategic Intelligence Private Limited
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 240 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,900 £Ü 6,844,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,400 £Ü 8,940,000
Printable PDF (Group User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,400 £Ü 11,733,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÃÀå °³¿ä

¼¼°è ¹ÙÀÌ¿À Ã˸нÃÀå ±Ô¸ð´Â 2023³â 6¾ï 760¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.3% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 9¾ï 2,520¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»ý¹° À¯·¡ ¹ÙÀÌ¿À Ã˸Ŵ °¢Á¾ »ê¾÷ ºÐ¾ß¿¡¼­ ÀϹÝÀûÀ¸·Î ¼®À¯ À¯·¡ ÇÕ¼º Ã˸Ÿ¦ ´ëüÇÒ ¼ö Àִ ģȯ°æ Ã˸ÅÀÔ´Ï´Ù. Ư¼ö È­ÇÐÁ¦Ç°°ú ¹ü¿ë È­ÇÐÁ¦Ç° »ý»ê¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

»ý¹°Ã˸ÅÀÇ °¡Àå µÎµå·¯Áø »ê¾÷Àû ÀÀ¿ëÀº ÀǾàǰÀÇ Çâ°ú Çâ·á¿¡ »ç¿ëµÇ´Â ÀÔüƯÀÌÀû È­ÇÕ¹°(۶ö È­ÇÕ¹°À̶ó°íµµ ÇÔ)ÀÔ´Ï´Ù. ۶ö¼º ¼ö»ê±â¸¦ °¡Áø Áß°£ È­ÇÕ¹°Àº ÀǾàǰ¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ È­ÇÐÁ¦Ç°ÀÇ Á¦Á¶¿¡ »ç¿ëµÉ »Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ ¿ø·á ÀǾàǰ¿¡µµ Á¸ÀçÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

À¯Çüº°·Î º¸¸é 2023³â ÇÏÀ̵å·Ñ¶óÁ¦´Â ¸®ÆÄ¾ÆÁ¦, ¾Æ¹Ð¶ó¾ÆÁ¦, ÇÁ·ÎÅ×¾ÆÁ¦ µî ´Ù¾çÇÑ »ý¹°ÇÐÀû ÀýÂ÷¿¡ ÇʼöÀûÀÎ È¿¼Ò·Î¼­ ¾÷°è ¸ÅÃâÀÇ 40%¸¦ Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î´Â 2023³â ½ÄÀ½·á Ä«Å×°í¸®°¡ 25%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ø·áº°·Î´Â ¹Ì»ý¹°ÀÌ 2023³â 2¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇßÀ¸¸ç, °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

Áö¿ªº°·Î º¸¸é 2023³â¿¡´Â ºÏ¹Ì Áö¿ªÀÌ ¸ÅÃâ ±âÁØ ÃÖ´ë Áö¿ªÀ¸·Î ºÎ»óÇϸç Å« ÆøÀÇ ¹ßÀü ±Ëµµ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À Ã˸нÃÀå¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, ½ÃÀåÀÇ ±âº» ±¸Á¶¿Í ÃֽŠ»óȲ, ÁÖ¿ä ÃËÁø¡¤¾ïÁ¦¿äÀÎ, ¼¼°è Àüü ¹× Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° ½ÃÀå ±Ô¸ð µ¿Çâ Àü¸Á(¼ö·®¡¤±Ý¾× ±âÁØ, 2017-2030³â), ¿ø·áº°¡¤À¯Çüº°¡¤¿ëµµº° »ó¼¼ µ¿Çâ, ÇöÀç ½ÃÀå °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÁöÇ¥

Á¦5Àå ¾÷°è Àü¸Á

Á¦6Àå ¼¼°è ½ÃÀå

Á¦7Àå ºÏ¹Ì ½ÃÀå

Á¦8Àå À¯·´ ½ÃÀå

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦12Àå ¹Ì±¹ ½ÃÀå

Á¦13Àå ij³ª´Ù ½ÃÀå

Á¦14Àå µ¶ÀÏ ½ÃÀå

Á¦15Àå ÇÁ¶û½º ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦18Àå ½ºÆäÀÎ ½ÃÀå

Á¦19Àå ÀϺ» ½ÃÀå

Á¦20Àå Áß±¹ ½ÃÀå

Á¦21Àå Àεµ ½ÃÀå

Á¦22Àå È£ÁÖ ½ÃÀå

Á¦23Àå Çѱ¹ ½ÃÀå

Á¦24Àå ºê¶óÁú ½ÃÀå

Á¦25Àå ¸ß½ÃÄÚ ½ÃÀå

Á¦26Àå »ç¿ìµð¾Æ¶óºñ¾Æ ½ÃÀå

Á¦27Àå ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ ½ÃÀå

Á¦28Àå ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE) ½ÃÀå

Á¦29Àå °æÀï »óȲ

Á¦30Àå ±â¾÷ °³¿ä

Á¦31Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Market Overview

In 2023, the biocatalyst market was valued at USD 607.6 million and is projected to grow at a CAGR of 6.3% from 2024 to 2030, reaching USD 925.2 million by 2030.

Biocatalysts sourced from biological origins offer an eco-friendly substitute for synthetic catalysts, commonly derived from petroleum, across various industrial sectors. They play a significant role in producing both specialty and commodity chemicals.

The advancement of cost-effective genetic engineering techniques has significantly contributed to their increased manufacturing. These bio-enzymes enable precise reactions, leading to desired outcomes with minimal waste and fewer by-products, bolstering their appeal in industrial processes.

Biocatalysts are progressively becoming functional in biotransformation procedures, and therefore, they have become significant nearly in all industries, mainly chemicals, and pharmaceuticals. The growth of lucrative and ecological chemoenzymatic processes strongly relies on the extensive accessibility and pertinency of enzymes with high performance, irrespective of ecological conditions.

Biocatalysis guarantees that compound molecules are made with high accuracy while meeting severe quality standards. This adhesive their cruciality in the pharmacological sector, where accurate quality and concentrations are important.

The most prominent industrial applications of biocatalysis are stereospecific compounds (also called chiral compounds) used for pharmaceuticals aromas and fragrances. Chiral hydroxyl moieties medium compounds exist in various APIs as well as they are used in the production of various chemicals for use in pharmaceuticals.

Key Insights

In 2023, hydrolases held 40% of the industry revenue, essential in diverse biological procedures such as lipases, amidases, and proteases.

Hydrolases feature prominently in permitted medications for conditions such as Alzheimer's, diabetes, and communicable diseases.

These enzymes are also used in detergent formulations to eliminate blood and protein stains, guaranteeing clean clothes.

In 2023, the food & beverages category had a 25% revenue share among biocatalyst applications.

Biocatalysts are vital enzymes in food processing and additive production.

Sectors such as brewing, bakery, dairy, meat, beverages, and sugar use bio-enzymes widely.

Biocatalysis is favored because of growing ecological awareness and sustainability requirements, providing advanced effectiveness and safety.

Its sustainability stems from working under mild conditions and decreasing energy use, waste, and by-products.

Constant innovation permits biocatalysis to evolve and fulfill diverse market requirements efficiently.

In 2023, microorganisms contributed USD 0.2 billion to the industry, and the category is projected to showcase significant growth.

Enzymes from microbial sources are lucrative, scalable for wholesale production, and have high enzyme content.

Microbe-based enzymes are strong, quicken reactions efficiently, produce diverse compounds, and provide cost benefits.

In 2023, the North American region arose as the largest revenue contributor to the worldwide biocatalyst industry and is projected to uphold a substantial development trajectory.

This development is mainly propelled by the strong pharmaceutical and food sectors dominant in the region, which cater as major industry drivers.

The United States and Europe comprise the two leading superpowers of the world pharmaceutical industry, with America capturing 49.1% of the market and Europe controlling 23.4% of the global turnover of pharmaceuticals in 2021.

Statics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) reveal the contribution of the United States and Europe was 64.4% and 16.2% respectively, newly drugs launched between 2016 and 2021.

Table of Contents

Chapter 1. Research Scope

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

Chapter 6. Global Market

Chapter 7. North America Market

Chapter 8. Europe Market

Chapter 9. APAC Market

Chapter 10. LATAM Market

Chapter 11. MEA Market

Chapter 12. U.S. Market

Chapter 13. Canada Market

Chapter 14. Germany Market

Chapter 15. France Market

Chapter 16. U.K. Market

Chapter 17. Italy Market

Chapter 18. Spain Market

Chapter 19. Japan Market

Chapter 20. China Market

Chapter 21. India Market

Chapter 22. Australia Market

Chapter 23. South Korea Market

Chapter 24. Brazil Market

Chapter 25. Mexico Market

Chapter 26. Saudi Arabia Market

Chapter 27. South Africa Market

Chapter 28. U.A.E. Market

Chapter 29. Competitive Landscape

Chapter 30. Company Profiles

Chapter 31. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â